XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Foreign currency hedging derivatives:
Interest rate swaps:
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
AOCI Attributable to Parent [Member]
Foreign currency hedging derivatives:
AOCI Attributable to Parent [Member]
Interest rate swaps:
Treasury Stock, Common
Retained Earnings [Member]
Beginning Balance (in shares) at Dec. 31, 2022       8,417,656            
Beginning Balance at Dec. 31, 2022 $ 116,125     $ 84 $ 40,342 $ 3,053     $ (29,099) $ 101,745
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 5,852                 5,852
Change in post retirement benefits, net of tax (93)         (93)        
Gain (loss) on derivatives   $ 383 $ (242)       $ 383 $ (242)    
Purchase of treasury stock (in shares)                 (1,318)  
Treasury Stock, Value, Acquired, Cost Method 23               $ (23)  
Restricted stock vested (in shares)       4,002            
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 0     $ 0            
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition 731       731          
Ending Balance (in shares) at Mar. 31, 2023       8,420,340            
Ending Balance at Mar. 31, 2023 $ 122,733     $ 84 41,073 3,101     (29,122) 107,597
Beginning Balance (in shares) at Dec. 31, 2023 8,655,384     8,655,384            
Beginning Balance at Dec. 31, 2023 $ 138,953     $ 86 43,265 5,301     $ (31,768) 122,069
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income 3,759                 3,759
Change in post retirement benefits, net of tax (127)         (127)        
Gain (loss) on derivatives 215 $ (382)         $ (382) $ 215    
Purchase of treasury stock (in shares)                 (17,773)  
Treasury Stock, Value, Acquired, Cost Method 343               $ (343)  
Restricted stock vested (in shares)       60,030            
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures 1     $ 1            
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition $ 739       739          
Ending Balance (in shares) at Mar. 31, 2024 8,697,641     8,697,641            
Ending Balance at Mar. 31, 2024 $ 142,815     $ 87 $ 44,004 $ 5,007     $ (32,111) $ 125,828